BPG is committed to discovery and dissemination of knowledge
Articles in Press
4/22/2026 5:32:18 AM | Browse: 1 | Download: 0
Publication Name World Journal of Gastrointestinal Oncology
Manuscript ID 119926
Country China
Category Oncology
Manuscript Type Correspondence
Article Title Letter to the Editor: Icaritin targeting epithelial-mesenchymal transition in colorectal cancer
Manuscript Source Invited Manuscript
All Author List Na-Qi Sun, Han-Xiao Zhang and Sai-Jun Mo
Funding Agency and Grant Number
Funding Agency Grant Number
Foundation of Henan Educational Committee No. 26A310017
College Student Innovation and Entrepreneurship Competitions No. 202510459174 and No. 2025cxcy639
Corresponding Author Sai-Jun Mo, Associate Professor, PhD, Department of Pathophysiology, School of Basic Medical Sciences, Zhengzhou University, No. 100 Science Avenue, Zhongyuan District, Zhengzhou 450001, Henan Province, China. sjmo@zzu.edu.cn
Key Words Icaritin; Colorectal cancer; Metastasis; Epithelial-mesenchymal transition; Wnt/β-catenin signaling pathway
Core Tip This commentary evaluates the study by Li et al, which suggests that icaritin inhibits colorectal cancer metastasis by reversing epithelial-mesenchymal transition and suppressing Wnt/β-catenin signaling. Although the findings are promising, changes in protein expression alone do not adequately confirm modulation of the pathway. Further research is necessary, including target localization studies and rescue experiments utilizing pathway activators, inhibitors, or gene modulation, to establish the dependence on Wnt/β-catenin signaling. For clinical translation, it is essential to validate targets, develop improved formulations to address issues of poor solubility and bioavailability, and conduct clinical trials to verify both efficacy and safety. Addressing these gaps will be crucial in establishing icaritin as a viable therapeutic strategy for the management of colorectal cancer.
Citation Sun NQ, Zhang HX, Mo SJ. Letter to the Editor: Icaritin targeting epithelial-mesenchymal transition in colorectal cancer. World J Gastrointest Oncol 2026; In press
Received
2026-02-10 00:56
Peer-Review Started
2026-02-10 01:00
First Decision by Editorial Office Director
2026-02-26 07:17
Return for Revision
2026-02-26 07:17
Revised
2026-03-06 15:48
Publication Fee Transferred
Second Decision by Editor
2026-04-22 02:35
Second Decision by Editor-in-Chief
Final Decision by Editorial Office Director
2026-04-22 05:32
Articles in Press
2026-04-22 05:32
Edit the Manuscript by Language Editor
Typeset the Manuscript
ISSN 1948-5204 (online)
Open Access This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Copyright ©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc.
Permissions For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website http://www.wjgnet.com